glp 1 and ulcerative colitis Pharmacological interventions for obesity in patients with inflammatory bowel disease: A systematic review of GLP-1 receptor agonist efficacy safety GLP-1 Weight Loss with Ulcerative
Description
The provider oversight matters
With this in mind, here were going to take a look at the pharmacokinetics of the two big boys (WeGovy and Mounjaro) and think about the impact those may have on the expected effects with type 1, and potentially the corroloary effects when used for other conditions
Side effects timeline: what to expect and when they fade Side effects follow their own timeline that is largely predictable but varies by individual
10.1126/sciadv.abn5345 39 JastreboffA.M.KaplanL.M.FrasJ.P.WuQ.DuY.GurbuzSet al (2023)
When I feel like it, I go downstairs and work out
